Susquehanna International Group, LLP Atara Biotherapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$0.44 - $1.22 $29,594 - $82,057	-67,260 Reduced 76.94%	20,155 $13,000
Q4 2023 Feb 14, 2024	SELL	$0.23 - $1.74 $29,078 - $219,984	-126,428 Reduced 59.12%	87,415 $44,000
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.31 $79,937 - $130,960	56,693 Added 36.08%	213,843 $316,000
Q2 2023 Aug 11, 2023	SELL	$1.5 - $3.04 $96,832 - $196,247	-64,555 Reduced 29.12%	157,150 $253,000
Q1 2023 May 16, 2023	BUY	$2.8 - $5.46 $460,921 - $898,797	164,615 Added 288.34%	221,705 $642,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $480,874 - $874,011	-168,728 Reduced 74.72%	57,090 $187,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $475,770 - $1.46 Million	166,937 Added 283.52%	225,818 $854,000
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $273,816 - $574,488	-58,383 Reduced 49.79%	58,881 $458,000
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $81,302 - $162,701	-9,633 Reduced 7.59%	117,264 $1.09 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $339,966 - $459,996	23,127 Added 22.29%	126,897 $2 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $360,731 - $538,539	30,086 Added 40.83%	103,770 $1.86 Million
Q2 2021 Aug 11, 2021	BUY	$12.89 - $16.58 $172,223 - $221,525	13,361 Added 22.15%	73,684 $1.15 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $59,206 - $87,624	4,229 Added 7.54%	60,323 $866,000
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $201,237 - $416,611	15,883 Added 39.5%	56,094 $1.1 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $71,388 - $95,045	5,989 Added 17.5%	40,211 $521,000
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $17,891 - $35,473	2,376 Added 7.46%	34,222 $498,000
Q1 2020 May 15, 2020	BUY	$5.69 - $17.78 $48,228 - $150,703	8,476 Added 36.27%	31,846 $271,000
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $400,991 - $618,241	-36,822 Reduced 61.17%	23,370 $385,000
Q3 2019 Nov 14, 2019	SELL	$12.03 - $19.94 $290,283 - $481,152	-24,130 Reduced 28.62%	60,192 $850,000
Q2 2019 Aug 16, 2019	BUY	$19.05 - $41.04 $212,102 - $456,939	11,134 Added 15.21%	84,322 $1.7 Million
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $479,240 - $1.03 Million	25,157 Added 52.38%	73,188 $1.47 Million
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $1.69 Million - $2.47 Million	48,031 New	48,031 $1.77 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.25B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account